作者
Allan Bayat,Guillem de Valles‐Ibáñez,Manuela Pendziwiat,Alexej Knaus,Kerstin Alt,Elisa Biamino,Annette Bley,Sophie Calvert,Patrick W. Carney,Alfonso Caro‐Llopis,Berten Ceulemans,Janice Cousin,Suzanne L. Davis,Vincent des Portes,Patrick Edery,Eleina England,Carlos R. Ferreira,Jeremy L. Freeman,Blanca Gener,Magali Gorce,Delphine Héron,Michael S. Hildebrand,Aleksandra Jezela‐Stanek,Pierre‐Simon Jouk,Boris Keren,Katja Kloth,Gerhard Kluger,Marius Kuhn,Johannes R. Lemke,Hong Li,Francisco Martı́nez,Caroline Maxton,Heather C. Mefford,Giuseppe Merla,Hanna Mierzewska,Alison M. Muir,Sandra Monfort,Joost Nicolai,Jennifer Norman,Gina L. O’Grady,Barbara Oleksy,Carmen Orellana,Laura Orec,Charlotte Peinhardt,Ewa Pronicka,Mónica Roselló,Fernando Santos‐Simarro,Eva Maria Christina Schwaibold,Alexander P.A. Stegmann,Constance T.R.M. Stumpel,Elżbieta Szczepanik,Iwona Terczyńska,Julien Thévenon,Andreas Tzschach,Patrick Van Bogaert,Roberta Vittorini,Sonja Walsh,Sarah Weckhuysen,Barbara Weissman,Lynne A. Wolfe,Alexandre Reymond,Pasquelena De Nittis,Annapurna Poduri,Heather E. Olson,Pasquale Striano,Gaëtan Lesca,Ingrid E. Scheffer,Rikke S. Møller,Lynette G. Sadleir
摘要
Abstract Objective Epilepsy is common in patients with PIGN diseases due to biallelic variants; however, limited epilepsy phenotyping data have been reported. We describe the epileptology of PIGN encephalopathy. Methods We recruited patients with epilepsy due to biallelic PIGN variants and obtained clinical data regarding age at seizure onset/offset and semiology, development, medical history, examination, electroencephalogram, neuroimaging, and treatment. Seizure and epilepsy types were classified. Results Twenty six patients (13 female) from 26 families were identified, with mean age 7 years (range = 1 month to 21 years; three deceased). Abnormal development at seizure onset was present in 25 of 26. Developmental outcome was most frequently profound (14/26) or severe (11/26). Patients presented with focal motor (12/26), unknown onset motor (5/26), focal impaired awareness (1/26), absence (2/26), myoclonic (2/26), myoclonic–atonic (1/26), and generalized tonic–clonic (2/26) seizures. Twenty of 26 were classified as developmental and epileptic encephalopathy (DEE): 55% (11/20) focal DEE, 30% (6/20) generalized DEE, and 15% (3/20) combined DEE. Six had intellectual disability and epilepsy (ID+E): two generalized and four focal epilepsy. Mean age at seizure onset was 13 months (birth to 10 years), with a lower mean onset in DEE (7 months) compared with ID+E (33 months). Patients with DEE had drug‐resistant epilepsy, compared to 4/6 ID+E patients, who were seizure‐free. Hyperkinetic movement disorder occurred in 13 of 26 patients. Twenty‐seven of 34 variants were novel. Variants were truncating ( n = 7), intronic and predicted to affect splicing ( n = 7), and missense or inframe indels ( n = 20, of which 11 were predicted to affect splicing). Seven variants were recurrent, including p.Leu311Trp in 10 unrelated patients, nine with generalized seizures, accounting for nine of the 11 patients in this cohort with generalized seizures. Significance PIGN encephalopathy is a complex autosomal recessive disorder associated with a wide spectrum of epilepsy phenotypes, typically with substantial profound to severe developmental impairment.